论文部分内容阅读
120例晚血患者随机分成2组,每组60人,治疗组接受安络化纤丸治疗,对照组接受常规护肝药物治疗,治疗12个月后,治疗组症状体征明显改善,肝纤维化指标下降。
One hundred and twenty patients with late blood were randomly divided into two groups (60 in each group). The treatment group received Anluo Huaxian Pill and the control group received conventional hepatoprotective drug treatment. After 12 months of treatment, the symptoms and signs of the treatment group were significantly improved, decline.